Sweet taste from glucose, fructose, and even the artificial sweetener sucralose can trigger cephalic phase insulin release in humans, but the response varies dramatically between individuals in both timing and magnitude.
Insulin release within 2 minutes of tastingGlucose and fructose reliably triggered cephalic phase insulin and C-peptide release, while sucralose produced comparable peak responses — but individual variability was dramatic across all stimuli
What the researchers found
Glucose and fructose elicited significant cephalic phase insulin and C-peptide release at 2 minutes. Sucralose did not produce a significant group-level response at 2 minutes but did elicit peak responses comparable to glucose and fructose. Individual variability in both timing and magnitude was substantial across all three stimuli.
Why it matters
Understanding how sweet taste alone triggers insulin release helps explain how the body prepares for food intake and has implications for artificial sweetener use, diabetes management, and appetite regulation.
The numbers in context
N=28; 3 sessions per participant; glucose, fructose, and sucralose tested; C-peptide and insulin measured; significant at 2 min for glucose and fructose
How the study worked
Crossover design with 28 healthy adults attending three sessions. Blood samples collected before and after oral stimulation with glucose, fructose, or sucralose. Plasma insulin and C-peptide measured to assess cephalic phase insulin release. Both group-level and individual-level analyses conducted.
What this study cannot tell us
Small sample (N=28). Only healthy adults studied — diabetic patients may respond differently. Single exposure per sweetener. The abstract has apparent data truncation. Short-term acute responses only. Individual variability was very large, making group-level conclusions less reliable.
How to read the evidence
This is a small but well-designed crossover study in healthy adults with objective biomarker outcomes (insulin and C-peptide). The within-subject design controls for individual variability, but the small sample size and significant heterogeneity limit generalizability.
When this study was published
Published in 2026, this study advances understanding of taste-triggered insulin release in the context of growing concerns about artificial sweetener metabolic effects.
The bigger picture
Cephalic phase insulin release represents the brain-pancreas connection — taste receptors in the mouth signal the brain, which then tells the pancreas to release insulin in anticipation of incoming nutrients. This peptide signaling pathway has implications for understanding why artificial sweeteners may affect metabolic health (they trigger insulin without corresponding sugar), why some people gain weight more easily than others (variable CPIR), and how diabetes disrupts the body's preparatory metabolic responses.
Questions still open
- Does the marked individual variability in CPIR predict metabolic disease risk or weight gain susceptibility?
- Do regular artificial sweetener users develop altered CPIR patterns that affect their metabolic health?
- Is CPIR impaired in people with type 2 diabetes, and could restoring it improve glucose management?
Common questions
What is cephalic phase insulin release?
Do artificial sweeteners cause insulin release?
Read the original research
Sweet stimuli induce cephalic phase insulin release to varying degrees in humans.
Physiology & behavior, 303, 115123
Citation
Pullicin, Alexa J; Lim, Juyun. (2026). Sweet stimuli induce cephalic phase insulin release to varying degrees in humans.. Physiology & behavior, 303, 115123. https://doi.org/10.1016/j.physbeh.2025.115123